4//SEC Filing
Henn Matthew R 4
Accession 0001193125-25-225103
CIK 0001609809other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:30 PM ET
Size
5.7 KB
Accession
0001193125-25-225103
Insider Transaction Report
Form 4
Henn Matthew R.
See Remarks
Transactions
- Award
Restricted Stock Units
2025-09-26+3,998→ 3,998 total→ Common Stock (3,998 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs will vest in a single installment on November 15, 2025, subject to the Reporting Person's satisfaction of the terms contemplated in the award agreement.The RSUs have no expiration date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001767321
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:30 PM ET
- Size
- 5.7 KB